CAN
ONC

Cetera Advisor Networks’s BeOne Medicines Ltd ONC Stock Holding History

Cetera Advisor Networks’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,234
Closed -$222K – 2883
2023
Q3 		$222K Buy
+1,234
New +$244K ﹤0.01% 2356
2020
Q3 		– Sell
-6
Closed -$1K – 3095
2020
Q2 		$1K Buy
+6
New +$977 ﹤0.01% 3393

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Cetera Advisor Networks's ONC Position: Q4 2023 in Review

Cetera Advisor Networks sold out of BeOne Medicines Ltd (ONC) in Q4 2023, closing a stake of 1,234 shares — an estimated $222K sold.

Cetera Advisor Networks first reported a position in ONC in Q2 2020 and held it in 2 quarters. The position peaked at $222K in Q3 2023. 204 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

  • Cetera Advisor Networks reported no remaining BeOne Medicines Ltd position as of Q4 2023 after selling out during the quarter.
  • Cetera Advisor Networks sold 1,234 BeOne Medicines Ltd shares in Q4 2023, an estimated $222K.
  • Cetera Advisor Networks first reported a position in BeOne Medicines Ltd in Q2 2020 and held it in 2 quarters.
  • Cetera Advisor Networks's BeOne Medicines Ltd position peaked at $222K in Q3 2023.
  • 204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on Cetera Advisor Networks's 13F filing for Q4 2023, filed 13 Feb 2024.